DK0385630T3 - 1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler - Google Patents

1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler

Info

Publication number
DK0385630T3
DK0385630T3 DK90301766.3T DK90301766T DK0385630T3 DK 0385630 T3 DK0385630 T3 DK 0385630T3 DK 90301766 T DK90301766 T DK 90301766T DK 0385630 T3 DK0385630 T3 DK 0385630T3
Authority
DK
Denmark
Prior art keywords
antivirals
imidazo
quinoline
amines
Prior art date
Application number
DK90301766.3T
Other languages
Danish (da)
English (en)
Inventor
John F Gerster
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Application granted granted Critical
Publication of DK0385630T3 publication Critical patent/DK0385630T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
DK90301766.3T 1989-02-27 1990-02-19 1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler DK0385630T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31603589A 1989-02-27 1989-02-27

Publications (1)

Publication Number Publication Date
DK0385630T3 true DK0385630T3 (da) 1997-05-12

Family

ID=23227183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90301766.3T DK0385630T3 (da) 1989-02-27 1990-02-19 1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler

Country Status (9)

Country Link
EP (1) EP0385630B1 (ko)
JP (1) JP2941336B2 (ko)
KR (1) KR0179992B1 (ko)
AU (1) AU630921B2 (ko)
CA (2) CA2010430A1 (ko)
DE (1) DE69029212T2 (ko)
DK (1) DK0385630T3 (ko)
ES (1) ES2094141T3 (ko)
NZ (1) NZ232602A (ko)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US4988815A (en) * 1989-10-26 1991-01-29 Riker Laboratories, Inc. 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
US5179107A (en) * 1990-09-07 1993-01-12 Schering Corporation Antiviral quinolinone compounds
WO1992004327A1 (en) * 1990-09-07 1992-03-19 Schering Corporation Antiviral compounds and antihypertensive compounds
EP0872478B1 (en) * 1991-03-01 2002-12-18 Minnesota Mining And Manufacturing Company Intermediates for the preparation of 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5179093A (en) * 1991-05-10 1993-01-12 Schering Corporation Quinoline-diones
US5268376A (en) * 1991-09-04 1993-12-07 Minnesota Mining And Manufacturing Company 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5266575A (en) * 1991-11-06 1993-11-30 Minnesota Mining And Manufacturing Company 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
US5395937A (en) * 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5622965A (en) * 1993-03-12 1997-04-22 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists
US5648516A (en) * 1994-07-20 1997-07-15 Minnesota Mining And Manufacturing Company Fused cycloalkylimidazopyridines
US5352784A (en) * 1993-07-15 1994-10-04 Minnesota Mining And Manufacturing Company Fused cycloalkylimidazopyridines
ES2149276T3 (es) * 1993-07-15 2000-11-01 Minnesota Mining & Mfg Imidazo(4,5-c)piridin-4-aminas.
US5644063A (en) * 1994-09-08 1997-07-01 Minnesota Mining And Manufacturing Company Imidazo[4,5-c]pyridin-4-amine intermediates
US5482936A (en) * 1995-01-12 1996-01-09 Minnesota Mining And Manufacturing Company Imidazo[4,5-C]quinoline amines
US5741908A (en) 1996-06-21 1998-04-21 Minnesota Mining And Manufacturing Company Process for reparing imidazoquinolinamines
US5840500A (en) * 1996-07-11 1998-11-24 Trega Biosciences, Inc. Quinoline derivatives and quinoline combinatorial libraries
CZ294563B6 (cs) * 1996-10-25 2005-02-16 Minnesota Mining And Manufacturing Company Sloučeniny představující modifikátory imunitní odezvy při léčení nemocí mediovaných TH2 buňkami a nemocí odvozených
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
GB0211649D0 (en) * 2002-05-21 2002-07-03 Novartis Ag Organic compounds
ATE338044T1 (de) 2002-07-23 2006-09-15 Teva Gyogyszergyar Zartkoeruen Herstellung von 1h-imidazoc4,5-c)chinolin-4- aminen ber 1h-imidazoc4,5-c)chinolin-4- phthalimidzwischenprodukte
JP2005537287A (ja) 2002-07-26 2005-12-08 テバ ジョジセルジャール レースベニュタールシャシャーグ 新規１Ｈ−イミダゾ［４，５−ｃ］キノリン−４−シアノ及び１Ｈ−イミダゾ［４，５−ｃ］キノリン−４−カルボキサミド中間体による１Ｈ−イミダゾ［４，５−ｃ］キノリン−４−アミン類の製造
JP2007502288A (ja) 2003-08-12 2007-02-08 スリーエム イノベイティブ プロパティズ カンパニー オキシム置換イミダゾ含有化合物
EP1658076B1 (en) 2003-08-27 2013-03-06 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
CA2537763A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
CA2540541C (en) 2003-10-03 2012-03-27 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AU2004291101A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
AU2004291122A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
JP4891088B2 (ja) * 2003-11-25 2012-03-07 スリーエム イノベイティブ プロパティズ カンパニー 置換されたイミダゾ環系および方法
US8802853B2 (en) 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
US8735421B2 (en) 2003-12-30 2014-05-27 3M Innovative Properties Company Imidazoquinolinyl sulfonamides
WO2005094531A2 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
CA2592904C (en) 2004-12-30 2015-04-07 3M Innovative Properties Company Chiral fused [1,2]imidazo[4,5-c] ring compounds
WO2006083440A2 (en) 2004-12-30 2006-08-10 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
JP2008530113A (ja) 2005-02-11 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド オキシムおよびヒドロキシラミン置換イミダゾ［４，５−ｃ］環化合物および方法
US8658666B2 (en) 2005-02-11 2014-02-25 3M Innovative Properties Company Substituted imidazoquinolines and imidazonaphthyridines
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
AU2007263281B2 (en) 2006-06-20 2012-12-06 Transgene S.A. Recombinant viral vaccine
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
US9227969B2 (en) 2013-08-14 2016-01-05 Novartis Ag Compounds and compositions as inhibitors of MEK
EP3445761A1 (en) * 2016-04-19 2019-02-27 Innate Tumor Immunity, Inc. Nlrp3 modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1271477A (en) * 1983-11-18 1990-07-10 John F. Gerster 1h-imidazo[4,5-c]quinolin-4-amines
CA1306260C (en) * 1985-10-18 1992-08-11 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines

Also Published As

Publication number Publication date
JP2941336B2 (ja) 1999-08-25
KR0179992B1 (ko) 1999-03-20
DE69029212D1 (de) 1997-01-09
EP0385630B1 (en) 1996-11-27
CA2010430A1 (en) 1990-08-27
ES2094141T3 (es) 1997-01-16
CA2355852A1 (en) 1990-08-27
AU5005490A (en) 1990-08-30
DE69029212T2 (de) 1997-05-22
KR910015575A (ko) 1991-09-30
AU630921B2 (en) 1992-11-12
EP0385630A3 (en) 1992-01-02
JPH0327380A (ja) 1991-02-05
NZ232602A (en) 1992-10-28
EP0385630A2 (en) 1990-09-05

Similar Documents

Publication Publication Date Title
DK0385630T3 (da) 1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler
AU632099B2 (en) Olefinic 1h-imidazo (4,5-c)quinolin-4-amines
DE69003575D1 (de) Formulierung, ein imidazo(4,5-c)quinolin-derivat enthaltend.
DK0516349T3 (da) 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
FI873054A (fi) Hydroformylering som utnyttjar litet flyktiga fosfinligander loesliga i organiska aemnen.
FI921279A (fi) Amino-b-lyasenzyminhibitorer som deodoranter.
FI900762A0 (fi) Tris-hydroximetylalkanestrar som fettimitationer med laog kalorihalt.
NO900741D0 (no) Tris-hydroxymethyl-lavere-alkanestere som fettimitasjoner.
FI892214A0 (fi) Kopparlegering foer anvaendning som motstaondssvetselektrod.
FI893605A0 (fi) Imidatso (4,5-b) pyridinderivat.
FI895483A (fi) Som slaglod anvaendbara kopparblandningar.
FI906270A (fi) Imidazo/4,5-c/pyridiner som antiosteoporotiska aemnen.
EP0417760A3 (en) Phenylalkanoyl substituted imidazo(4,5-c) pyridines
FI904017A0 (fi) Pyrido/3,4-b/1,4/bensoxazepiner, foerfarande foer framstaellning av dessa och anvaendning av dessa som laekemedel.
FI900940A0 (fi) Tryckt kretsskiva som foerhindrar elektromagnetisk interferens.
FI871980A0 (fi) Pyrazolo/3,4-b/pyridinderivat, foerfaranden och mellanprodukter foer deras framstaellning och deras anvaendning som herbicider.
KR880001629A (ko) 1,3,5-트리티안 유도체
FI905274A0 (fi) Katod som frigoer vaete.
MA21517A1 (fr) Tetrahydroimidazo (1,4) benzodiazepin-2-ones antivirales .
FI910281A0 (fi) Kopplingsarrangemang som bildar triangelpuls.
LT2332B (lt) Nitronaftalino monopakeisti sulfamidai kaip pusiauproduktai nesimetriniu 5-aminonaftalin-1-sulfamidudariniu gavimui
FI910951A0 (fi) Straolningshaerdbara bindemedelssystem med a-substituerade sulfonylfoereningar som fotoaktivatorer.
IT206781Z2 (it) Infisso particolarmente per esterni.
NO885331D0 (no) Ispropp som tunnel-luke.
NO905046L (no) Substituerte 6h-pyrido(4,6-6)karbazoler.